CD8A and neoplasm: Furthermore, RT followed by anti-PD-1 antibody significantly increased the CD8+/Treg ratio and PD-L1 expression in tumour cells, resulting in tumour growth suppression and prolonged survival in a mouse NSCLC model [57].